Russell Frank Company’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q1
$3.62M Buy
81,047
+16,936
+26% +$757K 0.01% 1524
2015
Q4
$2.49M Buy
64,111
+14,304
+29% +$555K ﹤0.01% 1705
2015
Q3
$1.59M Buy
49,807
+17,907
+56% +$570K ﹤0.01% 1983
2015
Q2
$1.05M Buy
31,900
+12,720
+66% +$420K ﹤0.01% 2287
2015
Q1
$790K Hold
19,180
﹤0.01% 2255
2014
Q4
$780K Buy
19,180
+17,637
+1,143% +$717K ﹤0.01% 2262
2014
Q3
$57K Sell
1,543
-26,701
-95% -$986K ﹤0.01% 2719
2014
Q2
$1.31M Buy
28,244
+7,723
+38% +$358K ﹤0.01% 1947
2014
Q1
$843K Sell
20,521
-1,365
-6% -$56.1K ﹤0.01% 2156
2013
Q4
$719K Sell
21,886
-11,992
-35% -$394K ﹤0.01% 2206
2013
Q3
$812K Buy
33,878
+33,807
+47,615% +$810K ﹤0.01% 2281
2013
Q2
$1K Buy
+71
New +$1K ﹤0.01% 3209